HLscience Co. Ltd (239610) — Cash Flow-to-Debt Ratio
HLscience Co. Ltd (239610) has a Cash Flow-to-Debt Ratio of -0.93x as of September 2025, meaning its operating cash flow of ₩-2.01 Billion could theoretically repay -1% of its total liabilities (₩2.15 Billion) in one year. See cash generation quality of HLscience Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
HLscience Co. Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for HLscience Co. Ltd across 11 annual periods. Also explore HLscience Co. Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for HLscience Co. Ltd (2014–2024)
Year-by-year debt coverage analysis for HLscience Co. Ltd. For market capitalisation and broader financial context, see HLscience Co. Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.11x | ₩-3.59 Billion | ₩3.23 Billion | ▼ -91.6% |
| 2023 | -0.58x | ₩-1.96 Billion | ₩3.38 Billion | ▼ -167.4% |
| 2022 | 0.86x | ₩3.95 Billion | ₩4.60 Billion | ▼ -13.7% |
| 2021 | 1.00x | ₩10.56 Billion | ₩10.61 Billion | ▼ -25.4% |
| 2020 | 1.33x | ₩14.97 Billion | ₩11.22 Billion | ▼ -17.6% |
| 2019 | 1.62x | ₩21.38 Billion | ₩13.21 Billion | ▲ +4.7% |
| 2018 | 1.55x | ₩13.02 Billion | ₩8.42 Billion | ▲ +21.9% |
| 2017 | 1.27x | ₩5.83 Billion | ₩4.60 Billion | ▲ +0.8% |
| 2016 | 1.26x | ₩5.53 Billion | ₩4.39 Billion | ▲ +16.0% |
| 2015 | 1.08x | ₩3.10 Billion | ₩2.86 Billion | ▲ +70.2% |
| 2014 | 0.64x | ₩2.31 Billion | ₩3.63 Billion | — |